Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Lung Cancer
99%
Pleura Effusion
67%
Tuberculostatic Agent
67%
Inflammation
61%
Lung Adenocarcinoma
60%
Protein Tyrosine Kinase Inhibitor
58%
Chronic Obstructive Lung Disease
58%
Mycobacterium Tuberculosis
58%
Case-Control Study
43%
Carbon Black
43%
Isoniazid
42%
Ethambutol
42%
Malignant Pleura Effusion
38%
Hepatotoxicity
38%
Asthma
38%
Lung Tuberculosis
38%
Drug Resistance
38%
Stevioside
38%
Prevalence
34%
Rifampicin
32%
Biological Marker
25%
Bovine Serum Albumin
25%
Erlotinib
23%
Streptomycin
22%
Mouse
22%
Pleurisy
22%
Chemotherapy
22%
Creatinine
22%
Antihypertensive Agent
21%
Tuberculosis
19%
Uvomorulin
19%
Human Immunodeficiency Virus Infection
19%
Latent Tuberculosis
19%
2,5-Dimethoxy-4-iodoamphetamine
19%
Cholinergic Receptor Stimulating Agent
19%
Nephrotoxicity
19%
Pharmacotherapy
19%
Plasma Protein
19%
Amino Acid
19%
Cigarette Smoke
19%
Bevacizumab
19%
Cisplatin
19%
Cross-Sectional Study
19%
Bronchiectasis
19%
Pemetrexed
19%
Staphylococcus Aureus
19%
Ureaplasma
19%
Uridine Diphosphate
19%
Protein Kinase C
19%
Medicine and Dentistry
Epidermal Growth Factor Receptor
77%
Chronic Obstructive Pulmonary Disease
68%
Multidrug Resistant Tuberculosis
58%
Lung Cancer
58%
Tuberculosis Treatment
51%
Pleura Effusion
48%
Six Minute Walk Test
44%
Odds Ratio
44%
Lung Adenocarcinoma
41%
Dentigerous Cyst
38%
Atmospheric Aerosol
38%
Hemoptysis
38%
Tyrosine-Kinase Inhibitor
38%
Neurosurgery
38%
Prevalence
38%
Silo-Filler's Disease
36%
Sputum Culture
32%
Chest Radiograph
30%
Lung Tuberculosis
29%
Artificial Respiration
25%
Biological Marker
25%
Tuberculosis
23%
Pleurisy
22%
Directly Observed Therapy
22%
Mortality Rate
21%
Disease
20%
Forced Expiratory Volume
20%
Diabetes
19%
Respiratory Care
19%
Cigarette Smoke
19%
Cross Sectional Study
19%
Tobacco Consumption
19%
Latent Tuberculosis
19%
Pemetrexed
19%
Myeloid-Derived Suppressor Cell
19%
Carboplatin
19%
Apoplexy
19%
Pneumopericardium
19%
4 Iodo 2,5 Dimethoxyamphetamine
19%
Malignant Pleural Effusion
19%
Culture Conversion
19%
Cervical Spinal Cord Injury
19%
Drug Therapy
19%
Smoking
19%
Fistula
19%
Positive Airway Pressure
19%
Lung Function Test
19%
Cisplatin
19%
Endobronchial Ultrasonography
19%
Bevacizumab
19%
Nursing and Health Professions
Obstructive Lung Disease
60%
Six Minute Walk Test
48%
Prevalence
38%
Neurosurgery
38%
Asthma
38%
Lung Cancer
38%
Lung Tuberculosis
29%
Case-Control Study
29%
Tuberculosis Control
28%
Chronic Respiratory Failure
23%
Airway Pressure
23%
Oxygen Therapy
23%
Mortality Rate
20%
Tidal Volume
20%
Forced Expiratory Volume
20%
Foreign Born
19%
Latent Tuberculosis
19%
Human Immunodeficiency Virus Infection
19%
Cross-Sectional Study
19%
Treatment Outcome
19%
Brain Injury
19%
Ventilator Weaning
19%
Oxygen
19%
Age Distribution
19%
Physical Disease by Body Function
19%
Mobilization
19%
Artificial Neural Network
19%
Lung Function Test
19%
Elderly Patient
19%
Population
19%
Medical Intensive Care Unit
19%
Early Diagnosis
19%
Thorax Radiography
19%
Home Respiratory Care
19%
Asthma Control Test
19%
Bronchiectasis
19%
Uridine Diphosphate
19%
Hypercapnia
19%
Patient Care
19%
Chewing Tobacco
19%
Carboplatin
19%
Cisplatin
19%
Tuberculosis
19%
Negative Pressure Ventilation
19%
Multi-Drug-Resistant Tuberculosis
19%
Nephrotoxicity
19%
Walking Distance
18%
Confidence Interval
18%
Diabetes Mellitus
17%
Hypoxemia
17%
